G0475 HCPCS Level II code: Hiv antigen/antibody, combination assay, screening

G0475 is the HCPCS code for “Hiv antigen/antibody, combination assay, screening” in CMS’s October 2026 release, in effect from Oct 1, 2026.

Official description

G0475

Hiv antigen/antibody, combination assay, screening

Short description: Hiv combination assay

HCPCS · United States

Medicare details

The indicators CMS publishes with G0475 in its October 2026 file. They describe Medicare’s handling, not another payer’s.

Medicare coverage
Carrier judgment
Medicare pricing
Physician fee schedule – Price established by carriers (e.g., not otherwise classified, individual determination, carrier discretion)
Type of service
Diagnostic laboratory
BETOS category
Other tests - other
Lab certification
Virology; General immunology
Added
Apr 13, 2015

Where G0475 sits

  1. 1G codesProcedures and professional services
  2. 2Active code G0475Hiv antigen/antibody, combination assay, screening

Source and release

Data release
HCPCS Level II · October 2026
Effective date
Oct 1, 2026
Publisher
CMS

This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.

Frequently asked questions

What does HCPCS code G0475 mean?

G0475 is the HCPCS code for “Hiv antigen/antibody, combination assay, screening” in CMS’s HCPCS Level II October 2026 release.

Does Medicare cover G0475?

CMS lists G0475’s Medicare coverage as “Carrier judgment” and its pricing as “Physician fee schedule – Price established by carriers (e.g., not otherwise classified, individual determination, carrier discretion)”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.

Which HCPCS Level II release does this page use?

It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.

G0468Federally qualified health center (fqhc) visit, ippe or awv; a fqhc visit that includes an initial preventive physical examination (ippe) or annual wellness visit (awv) and…G0469Federally qualified health center (fqhc) visit, mental health, new patient; a medically-necessary, face-to-face mental health encounter (one-on-one) between a new patient and a…G0470Federally qualified health center (fqhc) visit, mental health, established patient; a medically-necessary, face-to-face mental health encounter (one-on-one) between an…G0471Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health…G0472Hepatitis c antibody screening, for individual at high risk and other covered indication(s)G0473Face-to-face behavioral counseling for obesity, group (2-10), 30 minutesG0476Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical…G0477Drug test(s), presumptive, any number of drug classes; any number of devices or procedures, (e.g., immunoassay) capable of being read by direct optical observation only (e.g.…G0478Drug test(s), presumptive, any number of drug classes; any number of devices or procedures, (e.g., immunoassay) read by instrument-assisted direct optical observation (e.g.…G0479Drug test(s), presumptive, any number of drug classes; any number of devices or procedures by instrumented chemistry analyzers utilizing immunoassay, enzyme assay, tof, maldi…G0480Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily…G0481Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily…